Sana Biotechnology
SANA • NASDAQ
Sana Biotechnology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Steven D. Harr, with a market cap of $832.6M.
Market Cap$832.6M
Employees328.0
CEOSteven D. Harr
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Sana Biotechnology FAQ
Common questions about Sana Biotechnology
Sana Biotechnology is scheduled to report earnings for Q1 2026 on May 7, 2026.
Sana Biotechnology has approximately 328 employees.